These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29709506)

  • 1. Motor asymmetry and neuromelanin imaging: Concordance in Parkinson's disease.
    Prasad S; Saini J; Yadav R; Pal PK
    Parkinsonism Relat Disord; 2018 Aug; 53():28-32. PubMed ID: 29709506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system.
    Martín-Bastida A; Lao-Kaim NP; Roussakis AA; Searle GE; Xing Y; Gunn RN; Schwarz ST; Barker RA; Auer DP; Piccini P
    Brain; 2019 Jul; 142(7):2023-2036. PubMed ID: 31056699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron and neuromelanin imaging in basal ganglia circuitry in Parkinson's disease with freezing of gait.
    Zhang Y; Zhang C; Wang X; Liu Y; Jin Z; Haacke EM; He N; Li D; Yan F
    Magn Reson Imaging; 2024 Sep; 111():229-236. PubMed ID: 38777243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale functional network connectivity mediates the association between nigral neuromelanin hypopigmentation and motor impairment in Parkinson's disease.
    Yan S; Lu J; Li Y; Zhu H; Tian T; Qin Y; Zhu W
    Brain Struct Funct; 2024 May; 229(4):843-852. PubMed ID: 38347222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson's disease using neuromelanin-sensitive MRI.
    Liu Q; Wang P; Liu C; Xue F; Wang Q; Chen Y; Hou R; Chen T
    BMC Neurol; 2023 Aug; 23(1):301. PubMed ID: 37580712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional nigral neuromelanin degeneration in asymptomatic leucine-rich repeat kinase 2 gene carrier using MRI.
    Gao L; Gaurav R; Ziegner P; Ma J; Sun J; Chen J; Fang J; Fan Y; Bao Y; Zhang D; Chan P; Yang Q; Fan Z; Lehéricy S; Wu T
    Sci Rep; 2024 May; 14(1):10621. PubMed ID: 38729969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automatic Segmentation and Quantification of Nigrosome-1 Neuromelanin and Iron in MRI: A Candidate Biomarker for Parkinson's Disease.
    Ariz M; Martínez M; Alvarez I; Fernández-Seara MA; Castellanos G; ; Pastor P; Pastor MA; Ortiz de Solórzano C
    J Magn Reson Imaging; 2024 Aug; 60(2):534-547. PubMed ID: 37915245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker.
    Gaurav R; Yahia-Cherif L; Pyatigorskaya N; Mangone G; Biondetti E; Valabrègue R; Ewenczyk C; Hutchison RM; Cedarbaum JM; Corvol JC; Vidailhet M; Lehéricy S
    Mov Disord; 2021 Jul; 36(7):1592-1602. PubMed ID: 33751655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's disease.
    He N; Langley J; Huddleston DE; Chen S; Huang P; Ling H; Yan F; Hu X
    Neuroimage Clin; 2020; 28():102391. PubMed ID: 32889398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson's disease using convolutional neural network.
    Gaurav R; Valabrègue R; Yahia-Chérif L; Mangone G; Narayanan S; Arnulf I; Vidailhet M; Corvol JC; Lehéricy S
    Neuroimage Clin; 2022; 36():103250. PubMed ID: 36451356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromelanin-sensitive MRI correlates of cognitive and motor function in Parkinson's disease with freezing of gait.
    Huddleston DE; Chen X; Hwang K; Langley J; Tripathi R; Tucker K; McKay JL; Hu X; Factor SA
    medRxiv; 2023 Jul; ():. PubMed ID: 37461735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of a high-spatial-resolution voxelwise analysis of neuromelanin-sensitive imaging in early-stage idiopathic Parkinson's disease.
    Seong M; Park S; Sung YH; Kim EY
    BMC Med Imaging; 2023 May; 23(1):64. PubMed ID: 37202720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducible detection of nigral iron deposition in 2 Parkinson's disease cohorts.
    Langley J; He N; Huddleston DE; Chen S; Yan F; Crosson B; Factor S; Hu X
    Mov Disord; 2019 Mar; 34(3):416-419. PubMed ID: 30597635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Parkinson's disease patient displaying increased neuromelanin-sensitive areas in the substantia nigra after rehabilitation with tDCS: a case report.
    Ishikuro K; Hattori N; Imanishi R; Furuya K; Nakata T; Dougu N; Yamamoto M; Konishi H; Nukui T; Hayashi T; Anada R; Matsuda N; Hirosawa H; Tanaka R; Shibata T; Mori K; Noguchi K; Kuroda S; Nakatsuji Y; Nishijo H
    Neurocase; 2021 Oct; 27(5):407-414. PubMed ID: 34503372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep Learning-Based Neuromelanin MRI Changes of Isolated REM Sleep Behavior Disorder.
    Gaurav R; Pyatigorskaya N; Biondetti E; Valabrègue R; Yahia-Cherif L; Mangone G; Leu-Semenescu S; Corvol JC; Vidailhet M; Arnulf I; Lehéricy S
    Mov Disord; 2022 May; 37(5):1064-1069. PubMed ID: 35102604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderating effects of uric acid and sex on cognition and psychiatric symptoms in asymmetric Parkinson's disease.
    Constantin IM; Voruz P; Péron JA
    Biol Sex Differ; 2023 May; 14(1):26. PubMed ID: 37143121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PENCIL imaging: A novel approach for neuromelanin sensitive MRI in Parkinson's disease.
    Liu P; Wang X; Zhang Y; Huang P; Jin Z; Cheng Z; Chen Y; Xu Q; Ghassaban K; Liu Y; Chen S; He N; Yan F; Haacke EM
    Neuroimage; 2024 May; 291():120588. PubMed ID: 38537765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromelanin-sensitive magnetic resonance imaging: Possibilities and promises as an imaging biomarker for Parkinson's disease.
    Yan Y; Zhang M; Ren W; Zheng X; Chang Y
    Eur J Neurosci; 2024 May; 59(10):2616-2627. PubMed ID: 38441250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromelanin related ultra-high field signal intensity of the locus coeruleus differs between Parkinson's disease and controls.
    Wolters AF; Heijmans M; Priovoulos N; Jacobs HIL; Postma AA; Temel Y; Kuijf ML; Michielse S
    Neuroimage Clin; 2023; 39():103479. PubMed ID: 37494758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease.
    Krainc T; Monje MHG; Kinsinger M; Bustos BI; Lubbe SJ
    Mov Disord; 2023 Feb; 38(2):185-195. PubMed ID: 36350228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.